Deborshi Roy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Deborshi Roy has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Devinder Mangat
Department of Otolaryngology, University of Cincinnati, Cincinnati, Ohio
1 shared publicationDevinder S. Mangat
Department of Otolaryngology, University of Cincinnati School of Medicine, Cincinnati, OH, USA
1 shared publicationN Sadick
1 shared publicationNeil Sadick
Weill Medical College, Cornell University, Ithaca, New York
1 shared publication
Latest Publications
- 1 September 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (9) , 1134-1139
Clinical Trial of a Novel Filler Material for Soft Tissue Augmentation of the Face Containing Synthetic Calcium Hydroxylapatite Microspheres
The ideal injectable filler should yield great, long-lasting results, be biocompatible, reliable, safe, easy to use, and inexpensive. Radiesse (Bioform Inc., Franksville, WI) is a synthetic calcium hydroxylaptic filler that has all of the above qualities. OBJECTIVE To evaluate the effectiveness of Radiese as an injectable filler. Eighty-two patients who underwent facial soft tissue augmentation using Radiese from April 2003 to 2004 were enrolled in this study. Pre-filled sterile syringes were used to inject the material into the soft tissues of the face. At the 3 month and six month visits, the physicians and the patients were asked to evaluate the result. Eighty-two patients were injected with Radiesse. The most common area of injection was the melolabial folds. All patients were evaluated during the 3 month follow up visit. There was an overwhelmingly positive response to the look and feel of the implant, averaging 4.6 on a grading scale from 1 to 5, for the patients as well as the injecting physicians. Similar responses were found at the 6 month follow up visit. Preliminary data indicate that Radiesse is easy to use and effective with little or no associated morbidity.
- 1 September 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (9) , 1134-1139
Clinical Trial of a Novel Filler Material for Soft Tissue Augmentation of the Face Containing Synthetic Calcium Hydroxylapatite Microspheres
The ideal injectable filler should yield great, long-lasting results, be biocompatible, reliable, safe, easy to use, and inexpensive. Radiesse (Bioform Inc., Franksville, WI) is a synthetic calcium hydroxylaptic filler that has all of the above qualities. OBJECTIVE To evaluate the effectiveness of Radiese as an injectable filler. Eighty-two patients who underwent facial soft tissue augmentation using Radiese from April 2003 to 2004 were enrolled in this study. Pre-filled sterile syringes were used to inject the material into the soft tissues of the face. At the 3 month and six month visits, the physicians and the patients were asked to evaluate the result. Eighty-two patients were injected with Radiesse. The most common area of injection was the melolabial folds. All patients were evaluated during the 3 month follow up visit. There was an overwhelmingly positive response to the look and feel of the implant, averaging 4.6 on a grading scale from 1 to 5, for the patients as well as the injecting physicians. Similar responses were found at the 6 month follow up visit. Preliminary data indicate that Radiesse is easy to use and effective with little or no associated morbidity.
- 1 July 2005
- Published by Elsevier in Dermatologic Clinics
- Vol. 23 (3) , 549-559
Ablative Facial Resurfacing
- 1 July 2005
- Published by Elsevier in Dermatologic Clinics
- Vol. 23 (3) , 549-559
Ablative Facial Resurfacing
- 1 June 2005
- Published by Elsevier in Ophthalmology Clinics of North America
- Vol. 18 (2) , 259-270
Ablative Facial Resurfacing
- 1 June 2005
- Published by Elsevier in Ophthalmology Clinics of North America
- Vol. 18 (2) , 259-270
Ablative Facial Resurfacing